Latest News about BMY
Recent news which mentions BMY
FDA Approves Bristol-Myers' Opdualag, First LAG-3-Blocking Antibody Combo, For Melanoma Patients
March 21, 2022
Tickers
BMY
From Benzinga
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
March 20, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
March 18, 2022
From Benzinga
Why Eiger BioPharmaceuticals Stock Is Jumping Today
March 17, 2022
From Benzinga
Bristol-Myers Squibb And 2 Other Stocks Sold By Insiders
March 17, 2022
From Benzinga
From InvestorPlace
From Motley Fool
3 Top Stock Trades for This Week
March 15, 2022
From InvestorPlace
Got $1,000? Here's a Dirt-Cheap Big Pharma Stock to Buy
March 15, 2022
From Motley Fool
Why is Nektar Therapeutics (NKTR) Stock Down Today?
March 14, 2022
From InvestorPlace
Value investing is back: Here’s how to dodge the losers and spot the winners — with five stocks to consider
March 14, 2022
From MarketWatch
Why Nektar Therapeutics Stock Is Imploding Today
March 14, 2022
From Motley Fool
From Benzinga
Why Nektar Therapeutics Shares Are Falling Today
March 14, 2022
From Benzinga
From Benzinga
Should You Buy This Blue Chip Dividend Stock?
March 12, 2022
From Motley Fool
3 Unstoppable Growth Stocks to Buy in 2022 and Beyond
March 10, 2022
From Motley Fool
From Motley Fool
7 Drug Stocks To Consider After the Viatris Plunge
March 10, 2022
From InvestorPlace
Worried About the Stock Market? Here Are 2 Safe Investments to Buy and Hold for Decades
March 09, 2022
From Motley Fool
What Stocks Does 'The Big Short' Investor Michael Burry Own?
March 09, 2022
From Benzinga
8 Strong Uptrend Stocks to Buy on the Next Dip
March 09, 2022
Tags
AA
NYSE:CVX,NYSE:ABBV,NYSE:KO,NYSE:RTX,NYSE:LMT,NYSE:FCX,NYSE:BMY,NYSE:AA,NYSE:XOM,NYSE:PEP
LMT
From InvestorPlace
7 Biotech Stocks With Key Catalysts in March
March 09, 2022
From InvestorPlace
From Benzinga
From Benzinga
2 Biotech Stocks That Could Make You Richer
March 02, 2022
From Motley Fool
CTI BioPharma's Bone Marrow Cancer Drug Scores FDA Approval
March 01, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.